Analysts Set Repligen Co. (NASDAQ:RGEN) Price Target at $185.20

9 hours ago · Analysts Set Repligen Co. (NASDAQ:RGEN) Price Target at $185.20 Brokerages Set Definity Financial Co. (TSE:DFY) Target Price at C$54.70 MP Materials Corp. (NYSE:MP) Receives $22.10 Average PT from ...

$185.20
OFF

Analysts Set Repligen Co. (NASDAQ:RGEN) Price Target At $185.20

2 weeks from now

etfdailynews.com

$185.20
OFF

Repligen Co. (NASDAQ:RGEN) Receives $185.20 Consensus Price …

2 weeks from now

Dec 21, 2024 · Repligen Co. (NASDAQ:RGEN – Get Free Report) has earned a consensus rating of “Moderate Buy” from the thirteen ratings firms that are covering the company, Marketbeat …

americanbankingnews.com

$185.20
OFF

Repligen Co. (NASDAQ:RGEN) Receives $185.20 Average Target …

2 weeks from now

Dec 21, 2024 · Repligen Co. (NASDAQ:RGEN – Get Free Report) has been given an average recommendation of “Moderate Buy” by the thirteen brokerages that are currently covering the …

tickerreport.com

$158.14
OFF

Repligen Co. (NASDAQ:RGEN) Given Consensus ... - ETF Daily News

2 weeks from now

Dec 18, 2024 · Shares of RGEN opened at $158.14 on Wednesday. The company has a market cap of $8.86 billion, a PE ratio of -427.41, a price-to-earnings-growth ratio of 4.64 and a beta …

etfdailynews.com

$0.43
OFF

Repligen Co. (NASDAQ:RGEN) Receives Average Recommendation …

2 weeks from now

Dec 18, 2024 · Repligen (NASDAQ:RGEN - Get Free Report) last posted its quarterly earnings results on Tuesday, November 12th. The biotechnology company reported $0.43 earnings per …

marketbeat.com

$185.20
OFF

Repligen (RGEN) Stock Forecast And Price Target 2025 - MarketBeat

2 weeks from now

6 days ago · According to the 13 analysts' twelve-month price targets for Repligen, the average price target is $185.20. The highest price target for RGEN is $220.00, while the lowest price …

marketbeat.com

$211
OFF

Repligen Corporation: Target Price Consensus And Analysts ...

2 weeks from now

1 day ago · Repligen Corporation analysts consensus, targets, ratings and recommendations | Nasdaq: RGEN | Nasdaq. ... UBS Adjusts Repligen Price Target to $211 From $170, …

marketscreener.com

$0.43
OFF

Repligen (RGEN) Stock Price, News & Analysis - MarketBeat

2 weeks from now

2 days ago · Repligen Co. (NASDAQ:RGEN) announced its quarterly earnings data on Tuesday, November, 12th. The biotechnology company reported $0.43 earnings per share (EPS) for the …

marketbeat.com

$154.86
OFF

Repligen Co. (NASDAQ:RGEN) Receives Consensus …

2 weeks from now

3 days ago · Repligen Price Performance. NASDAQ RGEN opened at $154.86 on Friday. The stock's fifty day moving average price is $146.77 and its 200 day moving average price is …

marketbeat.com

6%
OFF

Repligen Corp. (RGEN) News, Articles, Events & Latest Updates

2 weeks from now

Repligen reports Q2 sales of $154.1 million, closely matching the consensus estimate. Adjusted gross margin fell to 49.6% from 50.2%, with an EPS of $0.33. ... Repligen Co. …

stocktwits.com

FAQs about Analysts Set Repligen Co. (NASDAQ:RGEN) Price Target at $185.20 Coupon?

What is the average 12 month price target for Repligen?

The average 12 month price target among analysts that have issued ratings on the stock in the last year is $185.20. A number of equities analysts have issued reports on the company. StockNews.com upgraded Repligen from a “sell” rating to a “hold” rating in a report on Friday, January 3rd. ...

Should you buy Repligen co (RGEN) stock?

Shares of Repligen Co. (NASDAQ:RGEN – Get Free Report) have earned an average recommendation of “Moderate Buy” from the thirteen research firms that are presently covering the stock, Marketbeat Ratings reports. Five analysts have rated the stock with a hold rating and eight have given a buy rating to the company. ...

Should I buy Repligen (RGEN)?

According to analysts, Repligen (RGEN) has a forecasted upside of 21.0% from its current price of $164.77, with an average rating score of 2.89 based on 8 buy ratings, 1 hold rating, and no sell ratings. Repligen has been the subject of 4 research reports in the past 90 days. ...

Is Repligen a good stock to buy?

Wolfe Research assumed coverage on shares of Repligen in a report on Thursday, November 14th. They set a “peer perform” rating for the company. Finally, Canaccord Genuity Group assumed coverage on Repligen in a research note on Tuesday, December 17th. They issued a “hold” rating and a $165.00 price target on the stock. ...

What is Repligen Corporation stock price?

Repligen Corporation's stock symbol is RGEN and currently trades under NASDAQ. It’s current price per share is approximately $123.97. How much money does Repligen Corporation make? Repligen Corporation generated $639.92M in revenue this past year and has a market capitalization of $6.99B. They earned $-2.11M in net income in the past year. ...

How much will Repligen (Repligen) earn per share?

On average, sell-side analysts expect that Repligen will post 1.54 earnings per share for the current year. (Get Free Report Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. ...